
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Recipient : LG Chem
Deal Size : Inapplicable
Deal Type : Inapplicable
LG Chem enters Chinese osteoarthritis treatment market
Details : Hyruan One (hyaluronic acid) is a small molecule, dihydrofolate reductase inhibitor, given intra-articularly. It is China’s first single-injection osteoarthritis treatment.
Product Name : Hyruan One
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 03, 2024
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Recipient : LG Chem
Deal Size : Inapplicable
Deal Type : Inapplicable
